CNS Pharmaceuticals, Inc. (CNSP) Capital expenditures 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$18,175FY2025 · since FY2018: $0 → $18,175
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18,175 | +334.0% |
| FY2024 | $4,188 | +7.4% |
| FY2023 | $3,901 | -11.8% |
| FY2022 | $4,422 | -23.1% |
| FY2021 | $5,748 | -68.0% |
| FY2020 | $17,945 | -10.8% |
| FY2019 | $20,120 | — |
| FY2018 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice